All News

Regulatory update @ACRheumDC Inflation Reduction Planned decrease in 10 drug prices including ETN Expect this may be gutted by new administration. Will follow and advocate for drug pricing @RheumNow #ACR24 https://t.co/ZrcMaLD6tu

Harkins @DrTrishHarkins et al. Novel diagnostic cytokines in treatment naive PMR. Elevations CXCL-9 (100%), MCP-1 (93%), IL-17A (83%), vs TNF (7%) and IL-6 (67%) @RheumNow #ACR24 Abstr#0881 https://t.co/DbYOn81QJH https://t.co/3eyre00D5d

119 Congress - prepare for change Obamacare subsidies set to expire NIH changes and possible reorg ACR champions are in gov positions for both parties Focus on affecting change that is practical, possible and improves rheumatology practice @ACRheumDC @LennMcD @RheumNow #ACR24 https://t.co/tcxixdlSWQ

@LennMcD @ACRheumDC Do policies affect medication access, costs, reimbursements, telehealth, or your life as a rheumatology provider or patients? Contact - quick and easy! https://t.co/TvMlXiIZQR @RheumNow #ACR24 https://t.co/plnUtl7Kml https://t.co/lFGx7hzlKy

#Blinded by results? 😊 #Ocular #involvement in #GPA 👇 Helped by #rituximab 👁️ #GPA Difficult Proptosis Pseudotumour Conjunctivitis Scleritis Vasculitis Ocular muscles - diplopia Small case series ‘author defined’ remission in 80% 👍 #RTX #abst0726 @rheumnow #ACR24 https://t.co/GHptelOTyv

https://x.com/Janetbirdope/status/1858148771579777129/photo/1

If high +ANA and NO #rheumatic #disease LOOK 👀 at #LIVER #Autoimmune #hepatitis And #alcoholic #liver #dx #ACRBest #ACR24 @rheumnow abst#0627 https://t.co/EVLUyvpBfD

Improved fertility in women with RA when treated with a Treat-to-Target (T2T) approach aimed at remission. Key findings: - Shorter time to pregnancy (TTP) in PreCARA cohort (84 days) vs. PARA cohort (196 days). - Increased TNF-inhibitor use and lower NSAID/prednisone use in the… https://t.co/YyD2lpXVRC https://t.co/LH5LMOH8al

@ACRheumDC Check out the ACR policy position statements Created by volunteer-led, non-partisan group of GAC committee - changes based on the needs of the ACR members @cdowneymd https://t.co/oAFfYUct4y @RheumNow #ACR24 https://t.co/MmVd8XYs0j

Half of the respondents chose #IL17i for #psoriatic #arthritis #PsA Rx for #Achilles #tendonitis Interesting as lots Of data On #enthesitis wIL23i Likely all Effective #PsA Rx helps #tenosynovitis some have ➡️ data on #efficacy ⬆️ bio rationale #ACR24 @RheumNow @ACRheum https://t.co/wzefjsfdaj

https://twitter.com/janetbirdope/status/1857188344100221389

If you are not at the table, you are on the menu https://t.co/c4anIn3aue @cdowneymd @ACRheumDC Join a committee RheumPAC Write a letter Write a post card at ACR Hub at #ACR24 Advocacy office hours with ACR staff #Act4Arthritis & Advocacy 101 on Cap Hill @RheumNow https://t.co/bpilydxEpB

The post hoc analysis of the SURPASS study evaluated predictors of radiographic spinal progression in axial spondyloarthritis patients treated with IL-17A (secukinumab) or TNF inhibitors over 2 years. Key findings: - New syndesmophytes: 18.2% (SEC 150 mg), 15.8% (SEC 300 mg),… https://t.co/jke6OHdPjZ

https://x.com/i/web/status/1858151857870315827

The future use of a panel of immunological urinary biomarkers as a liquid biopsy for the management of lupus nephritis. Plenary Abstr#1642 @RheumNow #ACR24 https://t.co/waSRVd7FV7

https://x.com/synovialjoints/status/1858151875658359020/photo/1

@LennMcD @ACRheumDC Current congress (118th) - very tight margins, paralyzed by the ‘24 elections. Now in lame duck Many ACR policies made into bills - PA, step rx, copay accumulator, workforce, loan repayment, incr Rx transparency Needs to be passed into law @RheumNow #ACR24 https://t.co/1elEUiUAmh

https://x.com/ericdeinmd/status/1858153751158132967/photo/1

@DrLauraCoates presented Sex differences in clinical presentations of PsA: -Women present >polyarthritis, enthesitis and worse PROs which translates to ⬆️ DAPSAs in spite of less Rx progression. -Men more oligoarthritis, axial involvement, higher skin disease. #ACR24… https://t.co/iapZF0nZWX https://t.co/jZ79WfxZwh

🔥Sex matters in PsA 🔑Differences in : ➡️clinical phenotypes ➡️radiographic progression ➡️disease impact ➡️pt perception of disease ➡️response to Rx #ACR24 @RheumNow https://t.co/iOXQmoxgp0

https://x.com/CaoilfhionnMD/status/1858154269611856207/photo/1

Dr @andreafava presents their noninvasive biomarker panel that predicted the probability of histologically active LN. Panel outperformed UPCR, C3, C4 & antidsDNA. Aid in clinical-decision making? Lots of potential for monitoring tx response. @Rheumnow #ACR24 abs1642 #ACRbest https://t.co/C7ZNdvbIQ7

@LennMcD @ACRheumDC Many ACR priorities in bills, needs to be passed in law Victories: Incr NIH biomedical research funding, added to DoD funds Medicare reimbursem and telehealth needs addressed by lame duck congress Get involved, reach out, write letters @RheumNow #ACR24 https://t.co/7oCvUFWpx4

Impressive Plenary @andreafava just finished Novel urine protein panel id 12 proteins that predict NIH activity on renal bx better than existing options Improving at 3 mos predicts response at 1 year Could reduce biopsies / modulate tx! #ACR24 @RheumNow Abstr#1642 #ACRbest https://t.co/Gi6u6hAGzj

"We look forward to Carol Langfords upcoming leadership at ACR and its newfound focus on ANCA vasculitis as the most important disease" 😆😂 -Phil Seo #ACR24 @RheumNow

A study presents a novel urinary biomarker panel that predicts histologically active lupus nephritis (LN) with high accuracy. Key findings: - AUC of 90% for predicting NIH Activity Index > 2, outperforming traditional biomarkers. - Identified 12 critical proteins linked to… https://t.co/6ZhqNaxpQM

https://x.com/i/web/status/1858155632609878365

Topics

All News

Do you get our email newsletter?